FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Guide on CAR T Cell Product Development

[ Price : $8.95]

Federal Register notice: FDA makes available a final guidance entitled Considerations for the Development of Chimeric Antigen Rece...

Draft Guide on Race/Ethnicity Trial Data

[ Price : $8.95]

Federal Register notice: FDA makes available a draft guidance entitled Collection of Race and Ethnicity Data in Clinical Trials an...

Hold Lifted on INmune Alzheimers Trial

[ Price : $8.95]

FDA lifts a 2022-imposed clinical hold against INmune Bios XPro (XPro1595; pegipanermin) and its Alzheimers disease clinical trial...

Feds Looking at Medical Record AI: Bloomberg

[ Price : $8.95]

Bloomberg Law says the Justice Department is looking into the use of AI in electronic health records to push doctors to prescribe ...

Enhertu sBLA Priority Review for Solid Tumors

[ Price : $8.95]

FDA accepts for priority review an AstraZeneca and Daiichi Sankyo supplemental BLA for Enhertu (trastuzumab deruxtecan) for treati...

Ban Skin Shock Devices: 29 Associations

[ Price : $8.95]

Some 29 advocacy groups call on FDA to act quickly to finalize a ban on electric skin shock devices used to treat self-injurious o...

CGMP Violations at Thailands S&J International

[ Price : $8.95]

FDA warns Thailands S&J International Enterprises about CGMP violations in its production of finished drugs and refusing to allow ...

Court Orders FDA Hetlioz Action

[ Price : $8.95]

The DC federal court orders FDA to act on a Vanda sNDA for a Hetlioz indication to treat jet lag disorder or schedule a hearing on...

CAR T-Cell Development Considerations Guide

[ Price : $8.95]

FDA posts a guidance entitled Considerations for the Development of Chimeric Antigen Receptor T Cell Products.

Guide on Race/Ethnicity Data Reporting

[ Price : $8.95]

FDA releases a draft guidance entitled Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regul...